Envoy Medical (NASDAQ:COCH) and Demant A/S (OTCMKTS:WILYY) Critical Review

Envoy Medical (NASDAQ:COCH) and Demant A/S (OTCMKTS:WILYY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for Envoy Medical and Demant A/S, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	3	0	3.00
Demant A/S	0	0	2	0	3.00

Envoy Medical currently has a consensus price target of $7.25, suggesting a potential upside of 238.79%. Given Envoy Medical’s higher possible upside, research analysts clearly believe Envoy Medical is more favorable than Demant A/S.

Earnings & Valuation

This table compares Envoy Medical and Demant A/S’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	131.08	-$29.91 million	N/A	N/A
Demant A/S	$3.26 billion	2.39	$260.63 million	N/A	N/A

Demant A/S has higher revenue and earnings than Envoy Medical.

Insider and Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Envoy Medical and Demant A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	-112.11%
Demant A/S	N/A	N/A	N/A

Risk and Volatility

Envoy Medical has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500. Comparatively, Demant A/S has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

Summary

Envoy Medical beats Demant A/S on 6 of the 9 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.